Institutional Ownership An2 Therapeutics, Inc. (ANTX)
This table provides information about the institutional ownership of An2 Therapeutics, Inc. (ANTX). We have compiled data on the 33 institutions that hold shares in the stock, with a total of 13.5 Million shares, which have been reported (via 13F filing form) to have a value of $17.5 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2024 Q3 2024 |
16,210
shares
|
$21,721
0.0% of portfolio
|
Q3 2024
Added 3.67%
|
|
|
ETF Managers Group, LLC
Summit, NJ |
Apr 17, 2023 Q1 2023 |
6,742
shares
|
$9,034
0.0% of portfolio
|
Q1 2023
New holding
|
|
|
Tower Research Capital LLC (Trc)
New York, NY |
Nov 14, 2024 Q3 2024 |
4,256
shares
|
$5,703
0.0% of portfolio
|
Q3 2024
Reduced 21.27%
|
|
|
Federated Hermes, Inc.
Pittsburgh, PA |
Nov 13, 2024 Q3 2024 |
3,006
shares
|
$4,028
0.0% of portfolio
|
Q3 2024
Added 227.81%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
303
shares
|
$406
0.0% of portfolio
|
Q3 2024
Reduced 98.26%
|
|
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
Nov 13, 2024 Q3 2024 |
300
shares
|
$402
0.0% of portfolio
|
Q4 2023
Added 50.0%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Nov 08, 2024 Q3 2024 |
54
shares
|
$72
0.0% of portfolio
|
Q3 2024
Reduced 94.71%
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Oct 10, 2024 Q3 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q3 2024
New holding
|